# Isosorbide mononitrate

Drug · id `cardio:isosorbide-mononitrate` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

Isosorbide mononitrate is a nitrate, a vasodilator (a medicine that widens blood vessels) taken by mouth in the form read here. The US label read, for generic isosorbide mononitrate tablets, lists the prevention and treatment of angina pectoris, chest pain from coronary artery disease. It also says the oral medicine does not act fast enough for the product to be useful in stopping an acute angina episode.

## Technical summary

RxNorm concept 28004 (isosorbide mononitrate, a precise ingredient of the RxNorm ingredient isosorbide, 6057; 28004 is the exact concept because 6057 names the isosorbide base, and RxNorm files isosorbide dinitrate as a separate ingredient, 6058); UNII LX1OH63030. MeSH has no descriptor for isosorbide mononitrate: the exact-label descriptor lookup returned an empty list (a term lookup returned term T126188, which was not used as an identifier). RxClass lists the FDA chemical class Nitrates and the established pharmacologic class Nitrate Vasodilator; the record is filed under the class page Nitrates on that evidence. The label read is the ANI Pharmaceuticals, Inc. generic tablet label, application ANDA075147, effective 2026-03-27 in openFDA (the plan row's set id). The original brand, other generic and repackager labels, and extended-release products were not read. This page records the label indication, the onset sentence and the mechanism sentence only: no trial result and no dose is given.

## Claims, with the population each applies to

## Context: People with angina pectoris due to coronary artery disease, as described in the US label of generic isosorbide mononitrate tablets

Recipient: Recipient not specified; Population: Patients with angina pectoris due to coronary artery disease, for prevention and treatment, as the indications section of the label states. The label passages read do not state an age range.; Care setting: Prescription medicine, as described in the US label; Geography: United States (label of the US Food and Drug Administration); Life stage: Not stated in the label passages read; Gestational age: Not reported; Postnatal age: Not reported; Follow-up: Not applicable (label statement)

### The US label of isosorbide mononitrate tablets (ANI Pharmaceuticals, Inc., application ANDA075147; the version dated 2026-03-27 in openFDA) calls isosorbide mononitrate an organic nitrate and a vasodilator with effects on both arteries and veins. It lists the prevention and treatment of angina pectoris due to coronary artery disease, and says the onset of action of the oral medicine is not sufficiently rapid for the product to be useful in aborting an acute anginal episode.

- Category: Description
- Evidence stage: Evidence stage not applicable
- Certainty: Certainty not assessed
- Applies to: Recipient: Recipient not specified; Population: Patients with angina pectoris due to coronary artery disease, for prevention and treatment, as the indications section of the label states. The label passages read do not state an age range.; Care setting: Prescription medicine, as described in the US label; Geography: United States (label of the US Food and Drug Administration); Life stage: Not stated in the label passages read; Gestational age: Not reported; Postnatal age: Not reported; Follow-up: Not applicable (label statement)
- Limitations: This claim records what one US label says the medicine is indicated for and how it describes the medicine. It is not a finding about how well the medicine works, and no trial result is recorded for it in this atlas. The label is for a generic tablet product; the original brand and other isosorbide mononitrate products were not read. The label passages read state no age range except where the claim says adults. Contraindications, warnings, interactions, use in pregnancy and in children, and dosing were not recorded. Labels change, and openFDA lists other versions with different dates. openFDA's own disclaimer says not to rely on it for decisions about medical care.
- Last checked: 2026-11-18
- Sources:
  1. Background: openFDA drug label record for isosorbide mononitrate tablets, ANI Pharmaceuticals, Inc. label: indication, description, pharmacology (Regulator, edition The openFDA drug label record for set id 06839534-85b8-42aa-b0e3-079ed236be44 (manufacturer ANI Pharmaceuticals, Inc., application ANDA075147), returned on 2026-11-18. The label text is dated 2026-03-27 (effective\_time). Other openFDA records of labels for the same ingredient from other sponsors and repackagers exist and were not used.) <https://api.fda.gov/drug/label.json?search=set_id:%2206839534-85b8-42aa-b0e3-079ed236be44%22&limit=1>
     Locator: results\[0\].openfda.application\_number\[0\]. Retrieved 2026-11-18T21:59:07Z. Source state: Current. Version fingerprint: 9a7c8ca6b07d747d351d5cc9f76811c56e281caa43fb44ff9e351116b6c7948e.
     How it applies: Application number of the label read.
  2. Background: openFDA drug label record for isosorbide mononitrate tablets, ANI Pharmaceuticals, Inc. label: indication, description, pharmacology (Regulator, edition The openFDA drug label record for set id 06839534-85b8-42aa-b0e3-079ed236be44 (manufacturer ANI Pharmaceuticals, Inc., application ANDA075147), returned on 2026-11-18. The label text is dated 2026-03-27 (effective\_time). Other openFDA records of labels for the same ingredient from other sponsors and repackagers exist and were not used.) <https://api.fda.gov/drug/label.json?search=set_id:%2206839534-85b8-42aa-b0e3-079ed236be44%22&limit=1>
     Locator: results\[0\].effective\_time. Retrieved 2026-11-18T21:59:07Z. Source state: Current. Version fingerprint: 9a7c8ca6b07d747d351d5cc9f76811c56e281caa43fb44ff9e351116b6c7948e.
     How it applies: Effective date of the label text read.
  3. Supports: openFDA drug label record for isosorbide mononitrate tablets, ANI Pharmaceuticals, Inc. label: indication, description, pharmacology (Regulator, edition The openFDA drug label record for set id 06839534-85b8-42aa-b0e3-079ed236be44 (manufacturer ANI Pharmaceuticals, Inc., application ANDA075147), returned on 2026-11-18. The label text is dated 2026-03-27 (effective\_time). Other openFDA records of labels for the same ingredient from other sponsors and repackagers exist and were not used.) <https://api.fda.gov/drug/label.json?search=set_id:%2206839534-85b8-42aa-b0e3-079ed236be44%22&limit=1>
     Locator: results\[0\].indications\_and\_usage\[0\]. Retrieved 2026-11-18T21:59:07Z. Source state: Current. Version fingerprint: 9a7c8ca6b07d747d351d5cc9f76811c56e281caa43fb44ff9e351116b6c7948e.
     How it applies: Label passage quoted in the research quote table (ISM-LB-04, ISM-LB-05).
  4. Supports: openFDA drug label record for isosorbide mononitrate tablets, ANI Pharmaceuticals, Inc. label: indication, description, pharmacology (Regulator, edition The openFDA drug label record for set id 06839534-85b8-42aa-b0e3-079ed236be44 (manufacturer ANI Pharmaceuticals, Inc., application ANDA075147), returned on 2026-11-18. The label text is dated 2026-03-27 (effective\_time). Other openFDA records of labels for the same ingredient from other sponsors and repackagers exist and were not used.) <https://api.fda.gov/drug/label.json?search=set_id:%2206839534-85b8-42aa-b0e3-079ed236be44%22&limit=1>
     Locator: results\[0\].description\[0\]. Retrieved 2026-11-18T21:59:07Z. Source state: Current. Version fingerprint: 9a7c8ca6b07d747d351d5cc9f76811c56e281caa43fb44ff9e351116b6c7948e.
     How it applies: Label passage quoted in the research quote table (ISM-LB-06).

## Connected pages

- Isosorbide mononitrate is a nitrate vasodilator (FDA established pharmacologic class in RxClass): Nitrates (`cardio:nitrates`)
- FDA label lists the prevention and treatment of angina pectoris due to coronary artery disease as the indication: Angina pectoris (`cardio:angina-pectoris`) [a claim, not a settled fact; see claim `cardio:claim-fda-isosorbide-mononitrate-label-indications` and its context]
- Files under this front: Medicines (`cardio:front-medicines`)

## Provenance

Content hash: 9dc01aae2d1c42cd7286ccdfa8d0e8fd2bbdc1eb7cca2c1d0a205a8ae2e706f1
Last substantive edit: 2026-11-18
Evidence last checked: 2026-11-18
